DWM
CRDF icon

Denver Wealth Management’s Cardiff Oncology CRDF Stock Holding History

Denver Wealth Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,235
Closed -$48K – 93
2025
Q2 		$48K Hold
15,235
– – 0.02% 87
2025
Q1 		$47.8K Hold
15,235
– – 0.02% 86
2024
Q4 		$66.1K Hold
15,235
– – 0.03% 82
2024
Q3 		$40.7K Hold
15,235
– – 0.02% 87
2024
Q2 		$33.8K Buy
15,235
+3,000
+25% +$11.3K 0.02% 83
2024
Q1 		$65.3K Sell
12,235
-8,000
-40% -$21.3K 0.03% 79
2023
Q4 		$29.9K Buy
20,235
+2,000
+11% +$2.42K 0.02% 75
2023
Q3 		$25.3K Hold
18,235
– – 0.02% 71
2023
Q2 		$26.8K Hold
18,235
– – 0.02% 71
2023
Q1 		$30.1K Buy
+18,235
New +$31.3K 0.02% 80

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return